IRIS
ABBADESSA, GIANMARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.103
NA - Nord America 2.188
AS - Asia 1.947
SA - Sud America 326
Continente sconosciuto - Info sul continente non disponibili 116
AF - Africa 38
OC - Oceania 2
Totale 8.720
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.037
US - Stati Uniti d'America 2.111
SG - Singapore 619
CN - Cina 467
IT - Italia 379
VN - Vietnam 273
IE - Irlanda 271
HK - Hong Kong 264
BR - Brasile 256
DE - Germania 130
KR - Corea 106
GB - Regno Unito 99
IN - India 96
JP - Giappone 45
CA - Canada 35
AR - Argentina 28
FI - Finlandia 24
MX - Messico 22
UA - Ucraina 20
FR - Francia 19
SE - Svezia 19
NL - Olanda 18
EC - Ecuador 16
AT - Austria 14
GR - Grecia 13
PL - Polonia 13
ID - Indonesia 10
IQ - Iraq 10
MA - Marocco 10
TR - Turchia 10
CZ - Repubblica Ceca 9
BE - Belgio 8
CO - Colombia 7
IL - Israele 7
PK - Pakistan 7
BD - Bangladesh 6
CH - Svizzera 6
EG - Egitto 6
VE - Venezuela 6
CL - Cile 4
ES - Italia 4
TN - Tunisia 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
PE - Perù 3
PY - Paraguay 3
RS - Serbia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BH - Bahrain 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
MY - Malesia 2
NG - Nigeria 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
SA - Arabia Saudita 2
SC - Seychelles 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EU - Europa 1
HN - Honduras 1
HT - Haiti 1
IR - Iran 1
LT - Lituania 1
MD - Moldavia 1
MT - Malta 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
RO - Romania 1
SN - Senegal 1
Totale 8.605
Salva come PNG Salva come JPEG
Città #
Moscow 1.096
San Jose 385
Dublin 271
Singapore 260
Hong Kong 257
Santa Clara 231
Ashburn 227
Council Bluffs 145
Hefei 134
Dallas 124
Ho Chi Minh City 106
Seoul 102
Chandler 70
Milan 63
Beijing 57
Hanoi 57
Munich 57
Bengaluru 49
Naples 47
Los Angeles 39
New York 37
Princeton 34
Roxbury 34
Cambridge 26
Rome 26
The Dalles 25
São Paulo 23
Memphis 21
Bremen 19
Da Nang 19
Jacksonville 19
Kochi 18
Orem 16
Caserta 15
Chicago 15
Phoenix 15
Atlanta 14
Medford 14
Ann Arbor 13
Boardman 12
Brasília 12
Helsinki 12
Tokyo 12
Toronto 12
San Francisco 11
Warsaw 11
Frankfurt am Main 10
Miano 10
Stockholm 10
Boston 9
Falkenstein 9
Mexico City 9
Bari 8
Brussels 8
Des Moines 8
Newark 8
Rio de Janeiro 8
Haiphong 7
Hải Dương 7
Amsterdam 6
Baghdad 6
Buffalo 6
Grafing 6
Guangzhou 6
Lappeenranta 6
Las Vegas 6
London 6
Montreal 6
Pasadena 6
Turku 6
Biên Hòa 5
Brno 5
Brooklyn 5
Buenos Aires 5
Bắc Ninh 5
Chennai 5
Curitiba 5
Hillsboro 5
Nuremberg 5
Porto Alegre 5
Redwood City 5
Thái Bình 5
Turin 5
Vienna 5
Viterbo 5
Wilmington 5
Zurich 5
Ankara 4
Aversa 4
Bologna 4
Bến Tre 4
Can Tho 4
Changsha 4
Guarulhos 4
Houston 4
Huế 4
Lviv 4
Nanjing 4
Ninh Bình 4
Norwalk 4
Totale 4.576
Salva come PNG Salva come JPEG
Nome #
Telemedicine application to headache: a critical review 181
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 178
Atypical Progressive Multifocal Leukoencephalopathy in a Kidney Transplant Recipient With Improving Symptoms After Immunocompetence Recovery 177
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 171
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 166
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 164
Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications 160
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series 159
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 154
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 153
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 152
Cd19 cell count at baseline predicts b cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab 150
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study 149
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 149
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic 149
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab 147
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic 146
e-Health and multiple sclerosis: An update 143
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review 141
Signs and symptoms of COVID-19 in patients with multiple sclerosis 141
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 140
Disability assessment using Google Maps 140
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail 137
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 137
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 133
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis 130
Behind the scenes: exploring neurological journal editors' work habits, decisions, and potential sources of conflict of interest 129
Viral pericarditis following ocrelizumab in a multiple sclerosis patient 128
Pain, quality of life, and religiosity in people with multiple sclerosis 128
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 127
Right phrenic nerve palsy following transcatheter radiofrequency current atrial fibrillation ablation: Case report 127
Social Media and Multiple Sclerosis in the Posttruth Age. 125
MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profiles 124
Readability Analysis of Online Headache and Migraine Information 122
Public engagement and neurology: An update 121
Digital work engagement among Italian neurologists 121
How to manage with telemedicine people with neuromuscular diseases? 120
The Use of Social Media and Digital Devices Among Italian Neurologists 119
Digital therapeutics in neurology 118
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study 117
Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study 116
Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning 116
Hemostatic factors in the pathogenesis of neuroinflammation in multiple sclerosis 115
Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study 114
Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online. 114
Heidenhain variant of Creutzefeldt-Jackob disease in a patient carrying the V210I mutation with asymmetric MRI abnormalities 113
Editorial: Bridging the gap between basic neurosciences and clinical neuroimmunology 112
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 112
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8 + T-Cell Proliferation in Patients With Multiple Sclerosis 108
Progressive multifocal leukoencephalopathy presenting with bilateral myoclonus: a case report 107
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 107
First the B cells fall, then the T cells follow: temporal immunological shift with ocrelizumab in multiple sclerosis 106
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis 106
Paraneoplastic syndrome or immune-related adverse event? A case of rhomboencephalitis in a patient treated with Pembrolizumab 104
Hemostasis Components as Therapeutic Targets in Autoimmune Demyelination 103
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study 99
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop) 98
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab 97
Glaucoma as a Tauopathy—Is It the Missing Piece in the Glaucoma Puzzle? 96
Emotional facial palsy: an unusual and rarely explored neurological sign 96
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab 94
Modulation of NCX1 expression in monocytes associates with multiple sclerosis progression 90
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis 89
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 86
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics 84
Reply to Wostyn, P. Targeting the Cerebrospinal Fluid Compartment in Glaucoma: Still the Dark Side of the Moon? Comment on “Passaro et al. Glaucoma as a Tauopathy—Is It the Missing Piece in the Glaucoma Puzzle? J. Clin. Med. 2023, 12, 6900” 80
Targeting shared pathways in tauopathies and age-related macular degeneration: implications for novel therapies 80
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression 78
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 76
Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis 73
ANTI-CD20 AGENTS RESHAPE THE PHENOTYPE AND FUNCTIONS OF CYTOTOXIC LYMPHOCYTES AND SELECTIVELY MITIGATE EBV-SPECIFIC CD8+ T CELL REACTIVITY IN PEOPLE WITH RELAPSING MULTIPLE SCLEROSIS 37
FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab 21
Serum miRNAs as biomarkers in Neurofibromatosis 1: New promising findings. 20
Totale 8.720
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.593
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.593
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022219 0 0 0 5 60 15 2 3 17 6 23 88
2022/2023416 63 12 9 11 35 18 2 11 222 6 11 16
2023/2024297 16 11 22 13 79 39 13 5 7 4 11 77
2024/20251.150 2 12 10 75 180 114 145 98 198 98 128 90
2025/20265.595 220 382 387 228 486 2.798 330 287 204 118 109 46
2026/2027852 36 129 321 366 0 0 0 0 0 0 0 0
Totale 8.720